Protagenic Therapeutics Inc

NASDAQ:PTIX  
3.00
+0.33 (+12.36%)
4:35:14 PM EDT: $2.89 -0.11 (-3.67%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Protagenic Therapeutics Inc Stock, NASDAQ:PTIX

149 Fifth Avenue, Suite 500, New York, New York 10010
United States of America
Phone: +1.212.994.8200
Number of Employees: 2

Description

Protagenic Therapeutics, Inc. is a biotechnology company, which engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It offers the PT00114 peptide-based formulations. The company was founded by Garo H. Armen, David A. Lovejoy, and Hartoun Hartounian on February 3, 1994 and is headquartered in New York, NY.